Vivo Bio Tech Limited (BOM:511509)
27.08
-0.10 (-0.37%)
At close: May 27, 2026
Vivo Bio Tech Market Cap
Vivo Bio Tech has a market cap or net worth of 600.92 million as of May 27, 2026. Its market cap has decreased by -4.16% in one year.
Market Cap
600.92M
Enterprise Value
1.15B
Revenue
514.24M
Ranking
n/a
PE Ratio
11.59
Stock Price
27.08
Market Cap Chart
Since November 16, 2004, Vivo Bio Tech's market cap has increased from 249.57M to 600.92M, an increase of 140.78%. That is a compound annual growth rate of 4.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 603.14M | -13.61% |
| Dec 31, 2025 | 698.16M | 16.58% |
| Dec 31, 2024 | 598.85M | 21.40% |
| Dec 29, 2023 | 493.31M | 12.03% |
| Dec 30, 2022 | 440.34M | -54.94% |
| Dec 31, 2021 | 977.27M | 38.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trident Texofab | 624.42M |
| Aeonx Digital Technology | 624.04M |
| Real Touch Finance | 621.94M |
| NCL Research & Financial Services | 620.79M |
| Tulsyan NEC | 620.60M |
| Asston Pharmaceuticals | 619.74M |
| Chiraharit | 616.46M |
| Dhanlaxmi Cotex | 615.50M |